These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1829521)

  • 21. Utilization of a modified special-cubic design and an electronic tongue for bitterness masking formulation optimization.
    Li L; Naini V; Ahmed SU
    J Pharm Sci; 2007 Oct; 96(10):2723-34. PubMed ID: 17506509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thermally reversible in situ gelling carbamazepine liquid suppository.
    El-Kamel A; El-Khatib M
    Drug Deliv; 2006; 13(2):143-8. PubMed ID: 16423803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Taste masking of ondansetron hydrochloride by polymer carrier system and formulation of rapid-disintegrating tablets.
    Khan S; Kataria P; Nakhat P; Yeole P
    AAPS PharmSciTech; 2007 Jun; 8(2):Article 46. PubMed ID: 17622121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solid state characterisation and taste masking efficiency evaluation of polymer based extrudates of isoniazid for paediatric administration.
    Keating AV; Soto J; Tuleu C; Forbes C; Zhao M; Craig DQM
    Int J Pharm; 2018 Feb; 536(2):536-546. PubMed ID: 28687346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polyacrylate resin microcapsules for taste masking of antibiotics.
    Friend DR
    J Microencapsul; 1992; 9(4):469-80. PubMed ID: 1403495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlled Dissolution of Griseofulvin Solid Dispersions from Electrosprayed Enteric Polymer Micromatrix Particles: Physicochemical Characterization and in Vitro Evaluation.
    Roine J; Kaasalainen M; Peurla M; Correia A; Araújo F; Santos HA; Murtomaa M; Salonen J
    Mol Pharm; 2015 Jul; 12(7):2254-64. PubMed ID: 26035734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of bioadhesive buccal tablets for felodipine and pioglitazone in combined dosage form: in vitro, ex vivo, and in vivo characterization.
    Palem CR; Gannu R; Yamsani SK; Yamsani VV; Yamsani MR
    Drug Deliv; 2011 Jul; 18(5):344-52. PubMed ID: 21351826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin, and roxithromycin.
    Bahal N; Nahata MC
    Ann Pharmacother; 1992 Jan; 26(1):46-55. PubMed ID: 1318761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving the oral bioavailability of sulpiride by a gastric-retained form in rabbits.
    Kohri N; Naasani I; Iseki K; Miyazaki K
    J Pharm Pharmacol; 1996 Apr; 48(4):371-4. PubMed ID: 8794985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The bitterness intensity of clarithromycin evaluated by a taste sensor.
    Tanigake A; Miyanaga Y; Nakamura T; Tsuji E; Matsuyama K; Kunitomo M; Uchida T
    Chem Pharm Bull (Tokyo); 2003 Nov; 51(11):1241-5. PubMed ID: 14600366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Viscoelastic properties of polyacrylic acid gels in mixed solvents.
    Chu JS; Yu DM; Amidon GL; Weiner ND; Goldberg AH
    Pharm Res; 1992 Dec; 9(12):1659-63. PubMed ID: 1488414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation of polymer-blended quinine nanocomposite particles by spray drying and assessment of their instrumental bitterness-masking effect using a taste sensor.
    Taki M; Tagami T; Ozeki T
    Drug Dev Ind Pharm; 2017 May; 43(5):715-722. PubMed ID: 27401130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An in-vitro-in-vivo taste assessment of bitter drug: comparative electronic tongues study.
    Maniruzzaman M; Douroumis D
    J Pharm Pharmacol; 2015 Jan; 67(1):43-55. PubMed ID: 25182780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved Release of Celecoxib from High Drug Loading Amorphous Solid Dispersions Formulated with Polyacrylic Acid and Cellulose Derivatives.
    Xie T; Taylor LS
    Mol Pharm; 2016 Mar; 13(3):873-84. PubMed ID: 26791934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbopol-mediated paracellular transport enhancement in Calu-3 cell layers.
    Li L; Mathias NR; Heran CL; Moench P; Wall DA; Smith RL
    J Pharm Sci; 2006 Feb; 95(2):326-35. PubMed ID: 16374869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of bitterness suppression of macrolide dry syrups by jellies.
    Tsuji E; Uchida T; Fukui A; Fujii R; Sunada H
    Chem Pharm Bull (Tokyo); 2006 Mar; 54(3):310-4. PubMed ID: 16508183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantification of protein concentration by the Bradford method in the presence of pharmaceutical polymers.
    Carlsson N; Borde A; Wölfel S; Kerman B; Larsson A
    Anal Biochem; 2011 Apr; 411(1):116-21. PubMed ID: 21184728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bifunctional capsular dosage form: novel fanicular cylindrical gastroretentive system of clarithromycin and immediate release granules of ranitidine HCl for simultaneous delivery.
    Rajput P; Singh D; Pathak K
    Int J Pharm; 2014 Jan; 461(1-2):310-21. PubMed ID: 24309435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of novel bioadhesive buccal formulation of diltiazem: in vitro and in vivo characterization.
    Shayeda ; Gannu R; Palem CR; Rao YM
    PDA J Pharm Sci Technol; 2009; 63(5):401-8. PubMed ID: 20158046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New macrolide antibiotics: clarithromycin and azithromycin.
    Stott GA
    Am Fam Physician; 1992 Sep; 46(3):863-9. PubMed ID: 1325106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.